ID: ALA5073719

Max Phase: Preclinical

Molecular Formula: C13H10O4

Molecular Weight: 230.22

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  O=C(O)CCC1=CC(=O)c2ccccc2C1=O

Standard InChI:  InChI=1S/C13H10O4/c14-11-7-8(5-6-12(15)16)13(17)10-4-2-1-3-9(10)11/h1-4,7H,5-6H2,(H,15,16)

Standard InChI Key:  SRGDDNIKFJKGLD-UHFFFAOYSA-N

Associated Targets(Human)

Quinone reductase 1 1746 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 230.22Molecular Weight (Monoisotopic): 230.0579AlogP: 1.86#Rotatable Bonds: 3
Polar Surface Area: 71.44Molecular Species: ACIDHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.73CX Basic pKa: CX LogP: 1.46CX LogD: -1.84
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.86Np Likeness Score: 1.30

References

1. Gong Q, Yang F, Hu J, Li T, Wang P, Li X, Zhang X..  (2021)  Rational designed highly sensitive NQO1-activated near-infrared fluorescent probe combined with NQO1 substrates in vivo: An innovative strategy for NQO1-overexpressing cancer theranostics.,  224  [PMID:34303080] [10.1016/j.ejmech.2021.113707]

Source